Longevity spinach isn’t spinach — it’s Gynura procumbens. Here’s what the traditional-medicine and preclinical evidence actually shows.
Longevity Spinach: What the Science Says About Gynura Procumbens Read More »
What prolongevity lifestyle coaching actually involves, who it’s for, and what to look for in a credible program.
What Does a Prolongevity Lifestyle Coach Actually Do? Read More »
A plain breakdown of every type of longevity test — biological age clocks, functional tests, blood panels, imaging — and which are actually worth doing.
Longevity Testing: What It Is and Which Tests Actually Matter Read More »
Longevity medicine explained: what it actually is, what a workup includes, and how it differs from wellness marketing.
Why regulators can’t agree if aging is treatable, and what ICD-11’s “old age” code and the FDA’s stance mean for longevity drugs in 2026.
Is Aging a Disease? The FDA and ICD-11 Debate Explained Read More »
Grip strength is one of the strongest predictors of healthy aging doctors have found. Here’s what the research shows — and what it doesn’t.
Grip Strength and Longevity: What the Science Actually Shows Read More »
Vagus nerve stimulation has solid clinical evidence in epilepsy and treatment-resistant depression, and the inflammatory reflex mechanism is genuinely compelling — but consumer tVNS devices for wellness have thin supporting evidence and modest effect sizes.
CRISPR-Cas9 is one of the most powerful biological tools ever developed — but self-experimentation carries off-target mutation risks, unresolved delivery challenges, and legal consequences that make it categorically different from other biohacking.
GLP-1 receptor agonists like semaglutide have compelling cardiovascular and metabolic data, but their use in metabolically healthy people for longevity benefits is still unproven — and the muscle loss risk is a real concern that’s often underplayed.
GLP-1s for Metabolic Reset: Should Healthy People Take Ozempic for Longevity? Read More »
Young blood transfusions captured Silicon Valley’s imagination after compelling mouse parabiosis studies — but the FDA has warned against commercial plasma clinics, the search for specific active factors has proven elusive, and ethical concerns remain unresolved.
